Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
Physiological Control of Respiration01:23

Physiological Control of Respiration

Introduction
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Sleep-Wake Cycles01:24

Sleep-Wake Cycles

Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The risk of biopsy of phaeochromocytomas and paragangliomas.

The lancet. Diabetes & endocrinology·2026
Same author

The Groundswell Community Surf Therapy Intervention for At-Risk Women and Changes in Body Acceptance, Resilience, and Emotional Regulation.

Global advances in integrative medicine and health·2024
Same author

Sympathetic overactivity and nocturnal diuresis in obstructive sleep apnea alter the response to hypertension therapy.

Clinical hypertension·2024
Same author

Association of whole-person eigen-polygenic risk scores with Alzheimer's disease.

Human molecular genetics·2024
Same author

CHRNA5 links chandelier cells to severity of amyloid pathology in aging and Alzheimer's disease.

Translational psychiatry·2024
Same author

Opposing brain signatures of sleep in task-based and resting-state conditions.

Nature communications·2023

Related Experiment Video

Updated: May 27, 2026

A Model to Simulate Clinically Relevant Hypoxia in Humans
09:54

A Model to Simulate Clinically Relevant Hypoxia in Humans

Published on: December 22, 2016

Cardiovascular Regulation in Obstructive Sleep Apnea.

Michael G Ziegler1, Milos Milic, Hamzeh Elayan

  • 1University of California, San Diego, Medical Center, Department of Medicine, 200 West Arbor Drive, San Diego, CA 92103-8341, USA.

Drug Discovery Today. Disease Models
|November 30, 2011
PubMed
Summary

Obstructive sleep apnea (OSA) frequently causes hypertension due to metabolic syndrome and intermittent hypoxia. Treating OSA modestly lowers blood pressure, but blocking sympathetic overactivity with specific agents is more effective for hypertensive patients with OSA.

More Related Videos

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
08:35

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction

Published on: August 17, 2022

Related Experiment Videos

Last Updated: May 27, 2026

A Model to Simulate Clinically Relevant Hypoxia in Humans
09:54

A Model to Simulate Clinically Relevant Hypoxia in Humans

Published on: December 22, 2016

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
08:35

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction

Published on: August 17, 2022

Area of Science:

  • Cardiology
  • Sleep Medicine
  • Endocrinology

Background:

  • Hypertension is a common complication in patients with obstructive sleep apnea (OSA), linked to metabolic syndrome.
  • Animal and human studies show intermittent hypoxia in OSA activates sympathetic nerves, damages endothelium, and impairs blood pressure regulation.

Purpose of the Study:

  • To explore the relationship between obstructive sleep apnea, hypertension, and sympathetic nervous system activity.
  • To evaluate the effectiveness of different treatments for hypertension in OSA patients.

Main Methods:

  • Review of animal studies on intermittent hypoxia and sympathetic nerve activity.
  • Analysis of human studies investigating sympathetic nerve responses and pressor reactions in OSA patients.
  • Evaluation of treatment outcomes for hypertension in OSA, including OSA treatment, beta-blockers, angiotensin antagonists, and diuretics.

Main Results:

  • Intermittent hypoxia in OSA stimulates sympathetic nerve activity and causes endothelial damage.
  • OSA treatment normalizes sympathetic responses but only modestly reduces blood pressure.
  • Beta-blockers and angiotensin antagonists effectively lower blood pressure in hypertensive OSA patients, while diuretics are less successful.

Conclusions:

  • Hypertension in OSA patients involves increased sympathetic nerve activity and metabolic syndrome.
  • Targeting sympathetic overactivity is crucial for managing hypertension in OSA.
  • Comprehensive treatment strategies considering both OSA and metabolic syndrome are necessary for hypertensive OSA patients.